Marca Nominativa depositada no INPI em 26/07/2022 por ElevateBio, LLC, processo nº 501680129, nas classes 42. Registro em vigor até 26/07/2032.
| Número do processo | 501680129 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 26/07/2022 |
| Data da concessão | 09/01/2024 |
| Vigência até | 26/07/2032 |
| Titular | ElevateBio, LLC |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development of vaccines and medicines; research and development services in the field of antibodies; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; biochemical research and development; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer; pharmaceutical research and development; product research and development; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical testing services and information in the field of cancer research and disease classification; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; testing, inspection, research, or development of pharmaceutical preparations for gene therapy.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501680129 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.